Coherent, Inc. · COHR · FY2026 Q3 · Calendar Q2 2026
Coherent sees strong AI-optics demand as capacity expands
Coherent’s current transcript analysis supports a constructive demand-and-capacity thesis: AI data-center optics demand, backlog visibility, and the 6-inch indium phosphide ramp are supporting growth and margins. The case remains dependent on production execution, product ramps, and sustained AI infrastructure spending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about COHR FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management highlighted an accelerated 6-inch indium phosphide expansion, a $2 billion NVIDIA equity investment and multiyear supply agreement, and an OCS opportunity revised above $4 billion after a bottleneck was removed. New OCS, CPO, multi-rail, and thermal-management contributions are expected across H2 2026 to H2 2027.
Guidance delta
Maintained; management indicated continued sequential revenue growth in Q4 and higher growth rates in FY27.
Key takeaways
- AI data-center optics demand remains strong, with backlog orders extending to 2028.
- The 6-inch indium phosphide ramp, pricing, and yield improvements are supporting margin expansion.
- OCS, CPO, multi-rail, and thermal products are the main cited future growth vectors.
- Higher Q4 capital expenditures will support capacity expansion.
- The NVIDIA partnership adds capital and long-term supply visibility.
Management priorities
- Expand indium phosphide capacity.
- Scale OCS and CPO offerings.
- Develop multi-rail systems and thermal-management products.
- Fund growth through higher Q4 capital expenditures.
- Support AI data-center bandwidth and energy-efficiency demand.
Follow COHR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Rosenblatt | Buy | Buy | Maintain | Sep 24, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 1, 2026 |
| Needham | Buy | Buy | Maintain | Aug 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Aug 13, 2026 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 13, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 2, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 7, 2026 |
| Stifel | Buy | Buy | Maintain | May 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jan 22, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Aug 14, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Jun 2, 2025 |
| Benchmark | Buy | Buy | Maintain | May 8, 2025 |
| Craig-Hallum | Buy | Buy | Maintain | Nov 7, 2024 |
| UBS | Buy | Buy | Maintain | Aug 7, 2023 |
| Loop Capital | Buy | Buy | Maintain | May 11, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 9, 2023 |
| William Blair | Perform | Market Perform | Maintain | Oct 17, 2022 |
| Berenberg | Hold | Buy | Downgrade | Jan 21, 2021 |
| Longbow Research | Neutral | Buy | Downgrade | Nov 12, 2020 |
| Piper Sandler | Overweight | Overweight | Maintain | May 28, 2020 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 24, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Dec 20, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 1, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| Northcoast Research | Buy | Buy | Maintain | Oct 25, 2016 |
| Sidoti & Co. | Buy | Buy | Maintain | Jun 15, 2015 |
| Noble Financial | Buy | Hold | Upgrade | Jan 25, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $278.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $400 | $277.83 | +43.8% | Aug 31, 2026 |
| Stifel Nicolaus | Ruben Roy | $420 | $337.34 | +51.0% | Aug 13, 2026 |
| Raymond James | Analyst unavailable | $448 | $348.88 | +61.0% | Aug 13, 2026 |
| Needham | Ryan Koontz | $420 | $355.64 | +51.0% | Aug 13, 2026 |
| Jefferies | Analyst unavailable | $420 | $355.64 | +51.0% | Aug 13, 2026 |
| Raymond James | Analyst unavailable | $435 | $368.65 | +56.4% | Jul 2, 2026 |
| Morgan Stanley | Meta Marshall | $330 | $326 | +18.6% | May 7, 2026 |
| Northland Securities | Analyst unavailable | $230 | $323.58 | -17.3% | May 7, 2026 |
| Raymond James | Analyst unavailable | $371 | $329.34 | +33.3% | May 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $412 | $329.89 | +48.1% | May 5, 2026 |
| Redburn Partners | Mike Harrison | $455 | $319.71 | +63.5% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $290 | $341.73 | +4.2% | Apr 20, 2026 |
| Morgan Stanley | Meta Marshall | $250 | $248.18 | -10.1% | Feb 23, 2026 |
| Northland Securities | Tim Savageaux | $170 | $204.12 | -38.9% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $198.78 | -15.5% | Feb 5, 2026 |
| Barclays | Tom O'Malley | $235 | $211 | -15.5% | Feb 5, 2026 |
| Morgan Stanley | Meta Marshall | $190 | $228.51 | -31.7% | Jan 30, 2026 |
| Stifel Nicolaus | Ruben Roy | $220 | $197.26 | -20.9% | Jan 22, 2026 |
| Susquehanna | Christopher Rolland | $235 | $197.26 | -15.5% | Jan 22, 2026 |
| Barclays | Tom O'Malley | $215 | $184.11 | -22.7% | Jan 15, 2026 |
| Morgan Stanley | Meta Marshall | $180 | $175.2 | -35.3% | Dec 17, 2025 |
| Raymond James | Simon Leopold | $210 | $177.35 | -24.5% | Dec 5, 2025 |
| Needham | Analyst unavailable | $190 | $155.44 | -31.7% | Nov 6, 2025 |
| Susquehanna | Analyst unavailable | $160 | $155.44 | -42.5% | Nov 6, 2025 |
| Morgan Stanley | Meta Marshall | $150 | $155.44 | -46.1% | Nov 6, 2025 |
| Susquehanna | Christopher Rolland | $150 | $120.79 | -46.1% | Oct 22, 2025 |
| Barclays | Tom O'Malley | $135 | $116.35 | -51.5% | Oct 20, 2025 |
| Morgan Stanley | Analyst unavailable | $120 | $122.35 | -56.9% | Oct 10, 2025 |
| Barclays | Tom O'Malley | $110 | $114.01 | -60.5% | Aug 14, 2025 |
| Morgan Stanley | Analyst unavailable | $97 | $106.74 | -65.1% | Aug 4, 2025 |
| Northland Securities | Tim Savageaux | $85 | $76.78 | -69.4% | Jun 2, 2025 |
| Raymond James | Strong Buy | $91 | $76.71 | -67.3% | Mar 24, 2025 |
| Loop Capital Markets | Ananda Baruah | $120 | $93 | -56.9% | Nov 7, 2024 |
| Rosenblatt Securities | Mike Genovese | $105 | $98.44 | -62.3% | Oct 22, 2024 |
| B.Riley Financial | Dave Kang | $86 | $102.07 | -69.1% | Oct 18, 2024 |
| Needham | James Ricchiuti | $120 | $104.62 | -56.9% | Oct 14, 2024 |
| Bank of America Securities | Vivek Arya | $108 | $94.27 | -61.2% | Oct 4, 2024 |
| Susquehanna | Christopher Rolland | $120 | $88.91 | -56.9% | Oct 1, 2024 |
| Craig-Hallum | Richard Shannon | $85 | $74.39 | -69.4% | Aug 16, 2024 |
| Needham | James Ricchiuti | $84 | $73.96 | -69.8% | Aug 16, 2024 |
| Rosenblatt Securities | Mike Genovese | $84 | $74.05 | -69.8% | Aug 16, 2024 |
| Needham | Alex Henderson | $70 | $71.53 | -74.8% | Aug 15, 2024 |
| Bank of America Securities | Vivek Arya | $75 | $66.7 | -73.0% | Aug 12, 2024 |
| B.Riley Financial | Dave Kang | $77 | $60.62 | -72.3% | Apr 1, 2024 |
| Needham | James Ricchiuti | $72 | $60.62 | -74.1% | Apr 1, 2024 |
| Barclays | Tom O'Malley | $60 | $45.16 | -78.4% | Jan 16, 2024 |
| Needham | Jim Ricchiuti | $52 | $43.46 | -81.3% | Dec 15, 2023 |
| Needham | James Ricchiuti | $50 | $34.79 | -82.0% | Oct 11, 2023 |
| Needham | Jim Ricchiuti | $64 | $54.74 | -77.0% | Jun 20, 2023 |
| Morgan Stanley | Analyst unavailable | $45 | $35.41 | -83.8% | Dec 13, 2022 |
| Deutsche Bank | Analyst unavailable | $50 | $36.82 | -82.0% | Nov 28, 2022 |
| Barclays | Thomas O'Malley | $65 | $71.55 | -76.6% | Jan 12, 2022 |
| Bank of America Securities | Vivek Arya | $80 | $71.24 | -71.2% | Jan 10, 2022 |
| Craig-Hallum | Richard Shannon | $100 | $74.49 | -64.1% | Jan 4, 2022 |
| Morgan Stanley | Meta Marshall | $82 | $70.5 | -70.5% | Dec 15, 2021 |
| Cowen & Co. | Paul Silverstein | $94 | $66.57 | -66.2% | Dec 13, 2021 |
| Northland Securities | Tim Savageaux | $75 | $64 | -73.0% | Nov 10, 2021 |
| Deutsche Bank | Sidney Ho | $75 | $62.66 | -73.0% | Sep 1, 2021 |
| Stifel Nicolaus | John Marchetti | $82 | $64.38 | -70.5% | Aug 11, 2021 |
Track every rating change on COHR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCoherent, Inc. specializes in advanced laser technologies, offering a comprehensive suite of products that includes lasers, laser-based solutions, and complete systems. These are deployed across a spectrum of uses, from commercial and industrial operations to critical scientific research. The company's operations are distinctly segmented into two primary areas: laser sources for Original Equipment Manufacturers (OEMs) and industrial lasers alongside integrated systems. Coherent handles the entire lifecycle of its offerings, from conceptual design and manufacturing to global marketing and ongoing service.…
Historical context
All COHR earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the COHR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-28T14:30:57.484478+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-28T14:30:57.481373+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-28. For educational purposes only; not investment advice.